Reagents and consumables

Ended Awarded

Contract number
75N91022F00015
Awardee
Awarding agency
Obligated
$11,622

Award facts

Contract value 100% obligated
$11,622.39 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

About this award

Roche Diagnostics Corporation was awarded an $11,622.39 firm fixed price delivery order for reagents and consumables to support the Department of Health and Human Services' National Institutes of Health's National Cancer Institute. The contract has no set-aside designation and requires performance at a place of Roche Diagnostics' choosing in Castleton, Indiana by October 25, 2022. As one of the largest private funders of cancer research in the world, this National Cancer Institute contract will likely help enable continued scientific progress in understanding and treating this disease.

Quick answers

Who was awarded contract 75N91022F00015?

75N91022F00015 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on July 26, 2022.

How much is contract 75N91022F00015 worth?

The government has obligated $11,622 on 75N91022F00015.

Is contract 75N91022F00015 an order under another contract?

Yes. 75N91022F00015 is a delivery order under 75N91019D00038, an indefinite delivery contract.

Was contract 75N91022F00015 competed?

The extent of competition for 75N91022F00015 was not competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award